Concurrent Bevacizumab with a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy for HER2− Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group
Titel:
Concurrent Bevacizumab with a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy for HER2− Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group
Auteur:
Rastogi, Priya Buyse, Marc E. Swain, Sandra M. Jacobs, Samuel A. Robidoux, André Liepman, Marcia K. Pajon, Eduardo R. Dy, Philip A. Posada Jr, Juan G. Melnik, Marianne K. Piette, Fanny Geyer Jr, Charles E. Mamounas, Elfetherios P. Wolmark, Norman